Fulgent Genetics (FLGT) Operating Income (2015 - 2026)
Fulgent Genetics (FLGT) posted Operating Income of -$34.6 million for Q1 2026, down 6824.4% sequentially from -$500000.0 in Q4 2025, and down 74.9% YoY from -$138.0 million in Q1 2025.
Fulgent Genetics (FLGT) Operating Income (2015 - 2026) Analysis & Trends
Fulgent Genetics (FLGT) has 12 years of Operating Income data on file, last reported at -$34.6 million in Q1 2026.
- Quarterly Operating Income fell 74.9% year-over-year to -$34.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70.2 million (up 2.41% YoY) and the FY2025 annual result came in at -$14.7 million, up 80.11% from the prior year.
- Operating Income eased to -$34.6 million in Q1 2026 per FLGT's latest filing, from -$500000.0 in the prior quarter.
- The five-year high for Operating Income was $201.9 million in Q1 2022, with the low at -$151.1 million in Q4 2023.
- Average Operating Income over 5 years is -$8.4 million, with a median of -$17.1 million recorded in 2024.
- Year-over-year, Operating Income plunged 18990.12% in 2023 and surged 96.9% in 2025.
- Fulgent Genetics' Operating Income stood at $800000.0 in 2022, then sank by 18990.12% to -$151.1 million in 2023, then soared by 89.32% to -$16.1 million in 2024, then surged by 96.9% to -$500000.0 in 2025, then plunged by 6824.4% to -$34.6 million in 2026.
- Business Quant data shows FLGT's Operating Income at -$34.6 million in Q1 2026, -$500000.0 in Q4 2025, and -$15.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -47.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.86 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.34 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 362.59 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -93.52 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 399.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 514.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 209.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 238.95 Mn |
| 10 | Fulgent Genetics | 642.94 Mn | 360.99 Mn | 21.49 Mn | -34.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.62 Mn |
| Dec 31, 2025 | -500,000.00 |
| Sep 30, 2025 | -15.35 Mn |
| Jun 30, 2025 | -19.71 Mn |
| Mar 31, 2025 | -19.80 Mn |
| Dec 31, 2024 | -16.14 Mn |
| Sep 30, 2024 | -17.08 Mn |
| Jun 30, 2024 | -18.91 Mn |
| Mar 31, 2024 | -21.80 Mn |
| Dec 31, 2023 | -151.12 Mn |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | -19.80 Mn |
| Mar 31, 2023 | -24.82 Mn |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Jun 30, 2022 | 12.79 Mn |
| Mar 31, 2022 | 201.93 Mn |
| Dec 31, 2021 | 150.86 Mn |
| Sep 30, 2021 | 159.27 Mn |
| Jun 30, 2021 | 98.90 Mn |